Related Experiment Videos
[MPO-ANCA related diffuse alveolar hemorrhage]
H Ohnishi1, R Fujiyama, H Tomioka
1Department of Respiratory Medicine, Nishi-Kobe Medical Center, Japan.
Summary
Myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related diffuse alveolar hemorrhage (DAH) presents with severe respiratory symptoms and poor prognosis. Early diagnosis and aggressive immunosuppressive therapy are crucial for managing MPO-ANCA DAH.
Area of Science:
- Pulmonology
- Rheumatology
- Nephrology
Background:
- Diffuse alveolar hemorrhage (DAH) is a rare but serious pulmonary condition.
- Myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA) positivity is associated with certain forms of DAH.
- Understanding the clinical characteristics of MPO-ANCA related DAH is essential for timely diagnosis and treatment.
Purpose of the Study:
- To define the clinical features of patients with MPO-ANCA related DAH.
- To identify key diagnostic markers and prognostic indicators in this patient cohort.
Main Methods:
- Retrospective evaluation of 17 MPO-ANCA-positive patients.
- Analysis of clinical data, including pulmonary involvement, laboratory findings, and diagnostic procedures.
- Assessment of treatment strategies and patient outcomes.
Main Results:
- Nine patients (52.9%) had pulmonary involvement, with 6 (35.3%) diagnosed with DAH.
- Patients with DAH exhibited elevated white blood cell counts, high C-reactive protein and MPO-ANCA titers, and microscopic hematuria.
- Bronchoalveolar lavage confirmed DAH in all affected patients.
- Aggressive treatment with methylprednisolone and cyclophosphamide showed some benefit, but the prognosis remained poor, with a significant mortality rate.
Conclusions:
- MPO-ANCA related DAH is characterized by specific clinical and laboratory findings.
- Prompt diagnosis via bronchoscopy and aggressive immunosuppressive therapy are vital.
- Mechanical ventilation and hemodialysis may be necessary, and vigilance for opportunistic infections is critical.